Pharmacist-led management of chronic pain in primary care : patient expectations, attitudes and concerns by Pharmacy-Led Management of Chronic Pain Study Team
condition.[1,2] However, the exact causes of errors made by
the most inexperienced doctors (first-year foundation trainee
(FY1) trainees) has yet to be empirically explored. In
particular, the role of the professional culture of medicine
(the language, thought processes, styles of communication,
customs and beliefs that characterise the profession of
medicine[3]) is unknown. This study (part of a larger
programme of work) aimed to explore the interplay between
self-reported causes of prescribing errors made by FY1
doctors and factors in their practice environments, such as
some aspects of professional culture.
Method
An in-depth qualitative exploration of the causes of prescribing
errors using a critical incident approach was conducted. Thirty
FY1 trainees, working in 17 hospitals and who had graduated
from 18 UK medical schools, were purposively selected for
interview. Doctors were requested, prior to interview, to
remember any prescribing errors that they had previously
made. During the interview, those errors were discussed in
detail. This discussion was followed by general questions
regarding doctors’ attitudes towards teaching and training about
prescribing and the perceived safety culture of their hospital.
Interviews were tape-recorded and transcribed verbatim. Data
were analysed by the constant comparison method. NHS
Research Ethics Committee approval was obtained.
Findings
Doctors’ accounts of error, of which there were 85 reported
incidents, demonstrated several aspects of professional culture
which were incongruent with a ‘safety culture’. Specifically,
prescribing errors were sometimes perceived as ‘silly errors’,
and respondents relied heavily on pharmacists and nurses to
identify and correct errors. These ‘safety nets’ detected the vast
majority of errors reported before they reached the patient. This
behaviour appeared to arise fromworking within a professional
culture that regarded prescribing as less important than other
areas of practice. A culture was observed that facilitates a
general acceptance of routine violations of prescribing rules;
however, these were sometimes understandable adaptations to
busy and stressful working conditions. Perhaps most worry-
ingly, FY1 trainees avoided using reference sources when
prescribing because of their perception of a medical culture in
which they should be seen as expert rather than learner.
The staunch hierarchical arrangement of medical teams
made it difficult for doctors to ask for help when prescribing,
particularly when on-call and during surgical placements.
This lack of support was discussed by many respondents and
was linked directly to several prescribing errors. Participants
also described errors that had arisen because they had blindly
followed the instructions of a more senior doctor, demon-
strating the existence of some cultural trends in which
communication was inhibited by authority.
Conclusions
Although errors were often detected prior to reaching the
patient, our findings pointed to the deficiencies in the safety
culture of medical practice, which were inextricably linked to
the professional culture of medicine. Although there is no
evidence that FY1 doctors make more errors, these findings
demonstrate the need for a change in medical culture as a
means to develop and strengthen the safety culture of
medical workplaces.
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Background
Chronic pain affects approximately half the population.[1]
Recovery is rare and management often unsatisfactory.
Most people are managed with prescribed analgesics, but
suboptimal prescribing, imperfect monitoring of repeat
prescriptions and concomitant use of nonprescription med-
icines means that treatment is often ineffective or inefficient.
The aim of an ongoing small randomised controlled trial
(RCT) is to compare pharmacist medication review of
patients with chronic pain with recommended changes
implemented by a general practitioner and with pharmacist
prescribing for patients with chronic pain. The Medical
Research Council framework for development and evaluation
of complex interventions[2] emphasises the importance of
identifying key components of an intervention and the
feasibility of delivery before undertaking the RCT. In line
with this, focus groups were conducted to explore patients’
beliefs and concerns about the proposed service before
finalising the intervention.
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Methods
This study was reviewed and approved by North of Scotland
Research Ethics Committee. Patients with chronic pain were
identified using a previously used computerised search
strategy of pain-related prescription records[3] in two
Grampian general practices. A random sample of 60 patients
from each practice was screened by a GP, and eligible
patients were invited to participate by a letter mailed by the
GP. Two focus groups were conducted, one in each practice.
The focus group schedule explored (1) patients’ previous
consultations with pharmacists, (2) methods of managing
pain other than medication, (3) importance of medication,
(4) views on consulting a pharmacist in the general practice
for pain, (5) what should happen in a consultation with a
pharmacist, (6) how a pharmacist would be able to help
manage pain and (7) what patients hoped to derive from
treatment. The focus groups were audiotaped, transcribed
verbatim and analysed thematically, independently, by two
researchers.
Results
Of 108 patients invited to participate, 13 agreed and 11
attended. Group one (n = 7) consisted of two men and five
women aged 20–73 years. Group two (n = 4) consisted of
one man and three women aged 66–80 years. Patients in
group two knew each other. Most patients expressed positive
views about the proposed intervention; pharmacists’ specia-
list training and knowledge were acknowledged. Patients
expressed an expectation that pharmacists would have more
time and be better equipped to monitor and educate about
medicines and their use. Concerns were expressed about
seeing the pharmacist in the practice that this risk being
viewed as another ‘layer’ in their care. A pharmacist-led
service might be used as a ‘quick track’ option instead of
seeing a GP, not as an addition to seeing a GP. The current
sample in both focus groups also expressed a preference for
an acute service located in a community pharmacy.
Conclusion
The opinions of these participants may not be generalisable
to a wider population and are about a service they have not
yet experienced. Nevertheless, the results show that patients
would accept pharmacist-led pain-related medication man-
agement and prescribing, as this is the area of their expertise.
Implications of the findings will be discussed in relation to
development of a pharmacist-led management of chronic
pain service.
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Background
Recently, hospital pharmacists have begun to offer medication
therapy adherence clinics (MTACs) for patients with diabetes,
asthma, human immunodeficiency virus (HIV) and few others
in some public hospitals in Malaysia. We wanted to examine
whether the MTAC service could be expanded to other disease
management setting like tuberculosis (TB), where high level of
medication adherence is required. MTAC service is a complex
intervention. To better understand a complex intervention, the
UK medical research council has recommended the use of
qualitative methods.[1] The aim of this study was to find out the
experiences of pharmacists running the MTACs, the percep-
tions of other health care professionals regarding the service
and the potential role of pharmacist in managing TB.
Methods
Qualitative methodology using semistructured interviews and
focus group discussion were employed. This study received
ethical approval from the Ministry of Health, Research and
Ethics Committee (MREC), Malaysia and was conducted at a
public hospital in the northern region of Malaysia. A focus
group discussion was held with four pharmacists where three of
themwereMTAC pharmacists. Two pharmacists were offering
the service to patients with diabetes and one was caring for the
HIV patients; the fourth pharmacist was responsible in
providing pharmaceutical care services to inpatients at the
respiratory wards, which includes TB patients. Semistructured
one-to-one interviews were carried out with three physicians
and three nurses. Of six, one physician and one nurse had
experience working with MTAC pharmacists, while the rest
were from the respiratory unit. Those from the respiratory unit
were recruited to have their views on the potential role of
pharmacist in managing TB. All interviews and discussions
were audiotaped, transcribed verbatim and analysed using
NVivo (version 8). Transcripts were thematically analysed
using the constant comparison approach.
Results
Pharmacists narrated their experiences of running the MTACs
with enthusiasm and satisfaction. They believed that they have
gained more knowledge, experience and confidence through
provision of pharmaceutical care and interactions with other
health care providers. The MTAC was felt to be strategically
located, convenient and utilised patients’ waiting time
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